Novo Nordisk Profit Margin

Novo Nordisk (NVO) currently reports a profit margin of 37.2% as of March 2026. That compares with 34.51% in the prior-year period — up 7.8% year over year. That is above the Healthcare sector average of 15.29%. Use the charts on this page to explore Novo Nordisk's profit margin history and peer comparisons.

Novo Nordisk's profit margin increased from 34.51% to 37.2% — a 7.8% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Novo Nordisk's profit margin of 37.2% is higher than the Healthcare sector average of 15.29%. That is roughly 143.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Novo Nordisk's current 37.2% should be judged against Healthcare norms (sector average: 15.29%) and against NVO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 37.2%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Novo Nordisk, and consider following NVO for alerts when major investors trade the stock.